EPISODE · May 30, 2025 · 46 MIN
The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease
from Keeping Current CME
Targeting the cardiovascular (CV)-kidney-metabolic (CKM) axis may improve outcomes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) by addressing interconnected metabolic, kidney, and CV risks. Credit available for this activity expires: 5/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002559?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.